Pemphigoid
Not recruitingStudy on Efgartigimod Alfa and Prednisone for Adults with Bullous Pemphigoid
- Disease:Pemphigoid
- Substances:Efgartigimod AlfaPrednisone
Spain- Participants:18–64 years · 65+ years
- Substances:Efgartigimod Alfa
- Sponsor:Argenx
Rare diseases
Investigational molecules
Locations
Back to Spain391 clinical trials in Granada, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on multiple cancer types including colorectal cancer, breast cancer, and glioblastoma. Studies are evaluating novel treatment approaches and combination therapies.
Advanced imaging techniques and targeted therapies are being investigated to improve patient outcomes.
Research targeting respiratory conditions with a focus on chronic obstructive pulmonary disease. Studies are examining new therapeutic approaches for moderate to severe cases.
Emphasis on reducing disease progression and improving quality of life for patients.
Clinical investigations in various skin conditions including plaque psoriasis and atopic dermatitis. Research focuses on innovative biological treatments.
Trials aim to develop more effective treatments for chronic skin conditions.
Studies investigating treatments for Alzheimer's disease in specific populations, particularly focusing on prevention and management of associated conditions.
Research aims to improve quality of life for patients with complex neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.